Drug Type CAR-NK |
Synonyms AntiMUC1 CAR-NK cells PersonGen Biomedicine, Antimucin1 CAR-NK cell therapy PersonGen Biomedicine |
Target |
Action modulators |
Mechanism MUC1 modulators(Mucin-1 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Phase 2 | China | 01 Jul 2016 | |
Hepatocellular Carcinoma | Phase 2 | China | 01 Jul 2016 | |
Malignant glioma of brain | Phase 2 | China | 01 Jul 2016 | |
MUC1 positive Solid Tumors | Phase 2 | China | 01 Jul 2016 | |
Non-Small Cell Lung Cancer | Phase 2 | China | 01 Jul 2016 | |
Pancreatic Cancer | Phase 2 | China | 01 Jul 2016 | |
Stomach Cancer | Phase 2 | China | 01 Jul 2016 | |
Triple Negative Breast Cancer | Phase 2 | China | 01 Jul 2016 |